Biological characteristics of osteoporosis drugs: the effect of osteoblast–osteoclast coupling
International Journal of Oral Biology
;
: 1-7, 2019.
Article
in English
| WPRIM
| ID: wpr-764035
ABSTRACT
Osteoporosis is a common disease characterized by bone mass reduction, leading to an increased risk of bone fracture, and it is caused by an imbalance of osteoblastic bone formation and osteoclastic bone resorption. Current osteoporosis drugs aim to reduce the risk of bone fracture, either by increasing osteoblastic bone formation or decreasing osteoclastic bone resorption. However, osteoblasts and osteoclasts are closely coupled, such that any reagent altering the differentiation or activity of one eventually affects the other. This tight coupling between osteoblasts and osteoclasts not only limits the therapeutic efficacy but also threatens the safety of osteoporosis drugs. This review will discuss the biological mechanisms of action of currently approved medications for osteoporosis treatment, focusing on the osteoblast–osteoclast coupling.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Osteoblasts
/
Osteoclasts
/
Osteogenesis
/
Osteoporosis
/
Population Characteristics
/
Bone Resorption
/
Fractures, Bone
Language:
English
Journal:
International Journal of Oral Biology
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS